Lionex GmbH

Lionex GmbH is an SME in Braunschweig, Germany that has taken part in 18 EU-funded projects since 2008, receiving €7.6M in EU funding and leading 2 as coordinator.

EU funding received€7.6M
EU projects18
As coordinator2
Running now0
First EU project2008
Latest project2020
CountryGermany
EU registration (PIC)999707609
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Lionex GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€6.8M · 15 projects
  • Horizon 2020€786k · 3 projects

Projects

18 EU-funded projects, newest first. Lionex GmbH led 2 of them as coordinator. Each links to the official record.

  • SMA-TBPartner

    A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €125ktheir share
  • BactiVaxPartner

    anti-Bacterial Innovative Vaccine Training Network.

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €253ktheir share
  • EMI-TBPartner

    Eliciting Mucosal Immunity to Tuberculosis

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €408ktheir share
  • IP4PLASMAPartner

    Industrial innovations based on EU intellectual property assets in the field of atmospheric plasma technology

    FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗

    €500ktheir share
  • RESPOCPartner

    Fast, cost-effective, user-friendly point of care (POC) instrument for detection of respiratory pathogens, including Streptococcus pneumoniae

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €111ktheir share
  • EURIPREDPartner

    European Research Infrastructures for Poverty Related Diseases

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €389ktheir share
  • PocketPartner

    Development of a low-cost point-of-care test for Tuberculosis detection

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €374ktheir share
  • DEMO-NOPERSISTCoordinator

    Demonstration of NOPERSIST results leading to novel, validated diagnostic tests for active human and bovine tuberculosis

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €248ktheir share
  • DIPROMONPartner

    Multimodular biomarker analysis workflow for diagnosis, prognosis and monitoring of drug treatment response in bladder cancer""

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €897ktheir share
  • CAPHIVPartner

    Early detection of HIV-1 using ultra-sensitive, rapid capacitive biosensor""

    FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

    €273ktheir share
  • RAPP-IDPartner

    Development of RApid Point-of-Care test Platforms for Infectious Diseases

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €477ktheir share
  • SYSTEMTBPartner

    Systems biology of Mycobacterium tuberculosis

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €479ktheir share
  • BURULIVACPartner

    Identification and development of vaccine candidates for Buruli Ulcer Disease

    FP7 (2007 to 2013) · 2010–2013 · Project on CORDIS ↗

    €263ktheir share
  • NOPERSISTCoordinator

    Novel strategies for the prevention and control of persistent infections

    FP7 (2007 to 2013) · 2010–2012 · Project on CORDIS ↗

    €534ktheir share
  • TRANSVACPartner

    European Network of Vaccine Development and Research

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €960ktheir share
  • HOMITBPartner

    Host and microbial molecular dissection of pathogenesis and immunity in tuberculosis

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €312ktheir share
  • AEROPATHPartner

    The identification, characterisation and exploitation of novel Gram-negative drug targets

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €639ktheir share
  • FAST-XDR-DETECTPartner

    Development of a two-approach plate system for the fast and simultaneous detection of MDR and XDR M. tuberculosis

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €330ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • animal husbandry
  • antibiotic resistance
  • antibiotics
  • bacteriology
  • biomolecules
  • biosensors
  • bladder cancer
  • coating and films
  • coronaviruses
  • drug discovery
  • drug resistance
  • entrepreneurship

Lionex GmbH is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime